AbbVie | Resultat Før Skatt



Pre Tax Profit Endring Dato
AbbVie USD 4.81B 1.54B 2024-12
Abbott USD 1.78B 252M 2025-03
ALKERMES USD 443.75M 333.52M 2024-12
Amgen USD 3.38B 111M 2024-12
AstraZeneca USD 3.4B 1.74B 2025-03
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eisai JPY 29.55B 13.99B 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 2.11B 1.55B 2025-03
J&J USD 13.63B 8.21B 2025-03
Medtronic USD 1.54B 455M 2025-01
Merck USD 5.22B 114M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Pacira USD 25.53M 24.05M 2024-12
Perrigo USD 151.3M 11.9M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.16B 20M 2025-03
UCB EUR 123M 464.07M 2024-06
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 423.5M 27M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Zoetis USD 773M 144M 2024-12



AbbVie Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.